Marc Luetgehetmann

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

Roeland Zoutendijk, Jurriën G.P. Reijnders, Ashley Brown et al. · Hepatology · 2011 · 171 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients

Aenne Harberts, Golda Schaub, Darius F. Ruether et al. · Clinical Gastroenterology and Hepatology · 2022 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II–Restricted, Hepatitis Delta Virus (HDV)–Specific T-Cell Responses Regardless of Clinical Status

Johanna Landahl, Jan Hendrik Bockmann, Christoph Scheurich et al. · The Journal of Infectious Diseases · 2018 · 31 citations

Life Sciences, Immunology, Infectious Diseases +17

Colitis Promotes a Pathological Condition of the Liver in the Absence of Foxp3+ Regulatory T Cells

Franziska Mathies, Niklas Steffens, Doerte Kleinschmidt et al. · The Journal of Immunology · 2018 · 23 citations

Life Sciences, Immunology, Pathology +17

Comparison of one commercial and two in‐house TaqMan multiplex real‐time <scp>PCR</scp> assays for detection of enteropathogenic, enterotoxigenic and enteroaggregative <i>Escherichia coli</i>

Andreas Hahn, Marc Luetgehetmann, Olfert Landt et al. · Tropical Medicine & International Health · 2017 · 20 citations · Full text

Medicine, Infectious Diseases, Microbiology +16